Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1986-04-11
1990-03-06
Rosen, Sam
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 3, 514 8, 514 7, 514 23, 536 187, A61K 3900
Patent
active
049064681
ABSTRACT:
An insulin activity messenger material and its precursor material are disclosed which have been isolated from hapatic plasma membranes that have been incubated with an enzyme known as a phosphtidylinositol-specific phospholipase C. The messenger material comprises a carbohydrate-based compound that exhibits the ability to modulate the activity of the insulin-sensitive enzymes pyruvate dehydrogenase, adenylate cyclase, acetyl CoA carboxyase, and low Km cAMP phosphodiesterase, and thereby effectuate the activity of insulin on the cellular level. The precursor material comprises an inositol containing glycolipid capable of phosphodiesteratic cleavage by a phosphatidylinositol-specific phospholipase C. Numerous diagnostic and therapeutic utilities are proposed, and testing procedures, materials in kit form, antibodies, and pharmaceutical compositions are likewise set forth.
REFERENCES:
Jarett et al-Chem. Abst., vol. 97 (1982) p. 85761z.
Rosen Sam
The Rockefeller University
LandOfFree
Insulin activity messengers, their antibodies, and thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin activity messengers, their antibodies, and thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin activity messengers, their antibodies, and thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-46490